Bohring–Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 12, 2015-12 ,pp. : 3161-3166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genotyping FOXG1 Mutations in Patients with Clinical Evidence of the FOXG1 Syndrome

By  

Molecular Syndromology, Vol. 3, Iss. 6, 2012-12 ,pp. : 284-287

Karger

Access to resources Recommend Favorite

Spectrum of Δ 7 -dehydrocholesterol reductase mutations in patients with the Smith–Lemli–Opitz (RSH) syndrome

By Yu Hongwei   Lee Mi-Hye   Starck Lena  

Human Molecular Genetics, Vol. 9, Iss. 9, 2000-05 ,pp. : 1385-1391

Oxford University Press

Access to resources Recommend Favorite

New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome

By Cox Timothy C.  

Human Molecular Genetics, Vol. 9, Iss. 17, 2000-10 ,pp. : 2553-2562

Oxford University Press

Access to resources Recommend Favorite

Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm

By Royer-Pokora Brigitte   Busch Maike   Beier Manfred   Duhme Constanze   de Torres Carmen   Mora Jaume   Brandt Artur   Royer Hans-Dieter  

Human Molecular Genetics, Vol. 19, Iss. 9, 2010-05 ,pp. : 1651-1668

Oxford University Press

Access to resources Recommend Favorite